In the latest session, Renalytix Plc ADR (NASDAQ: RNLX) closed at $1.04 up 20.93% from its previous closing price of $0.86. In other words, the price has increased by $+0.1800 from its previous closing price. On the day, 549300 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a deeper understanding of Renalytix Plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.59 and its Current Ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on January 18, 2022, initiated with a Buy rating and assigned the stock a target price of $30.
On January 04, 2022, BTIG Research started tracking the stock assigning a Buy rating and target price of $24.
On October 04, 2021, Guggenheim started tracking the stock assigning a Buy rating and target price of $28.Guggenheim initiated its Buy rating on October 04, 2021, with a $28 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RNLX now has a Market Capitalization of 49.61M and an Enterprise Value of 51.27M. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.56. Its current Enterprise Value per Revenue stands at 21.27 whereas that against EBITDA is -1.39.
Stock Price History:
Over the past 52 weeks, RNLX has reached a high of $4.04, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is 0.6611, while the 200-Day Moving Average is calculated to be 1.5216.
Shares Statistics:
For the past three months, RNLX has traded an average of 1.98M shares per day and 861.89k over the past ten days. A total of 46.89M shares are outstanding, with a floating share count of 46.30M. Shares short for RNLX as of Feb 29, 2024 were 1.27M with a Short Ratio of 0.25, compared to 601.79k on Jan 31, 2024.
Earnings Estimates
There are 2 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.07 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.09, while EPS last year was -$0.28. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.31 and -$0.37 for the fiscal current year, implying an average EPS of -$0.34. EPS for the following year is -$0.27, with 2 analysts recommending between -$0.27 and -$0.28.
Revenue Estimates
A total of 2 analysts believe the company’s revenue will be $950k this quarter.It ranges from a high estimate of $1.1M to a low estimate of $800k. As of the current estimate, Renalytix Plc ADR’s year-ago sales were $724k, an estimated increase of 31.20% from the year-ago figure. For the next quarter, 2 analysts are estimating revenue of $1.45M, an increase of 179.90% over than the figure of $31.20% in the same quarter last year. There is a high estimate of $1.6M for the next quarter, whereas the lowest estimate is $1.3M.
A total of 2 analysts have provided revenue estimates for RNLX’s current fiscal year. The highest revenue estimate was $4M, while the lowest revenue estimate was $3.2M, resulting in an average revenue estimate of $3.6M. In the same quarter a year ago, actual revenue was $3.4M, up 5.80% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $16.05M in the next fiscal year. The high estimate is $18M and the low estimate is $14.1M. The average revenue growth estimate for next year is up 345.80% from the average revenue estimate for this year.
